menu
    • menu

    Company profile for Ribocure Pharmaceuticals

    NEW Drugs in Dev: 3
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ribocure Pharmaceuticals AB is a newly established Swedish biotech company with a focus on developing cutting-edge RNA therapeutics. Specializing in rare diseases within the fields of cardiovascular, renal, and oncology, Ribocure is dedicated to discovering and developing groundbreaking drug assets using advanced oligonucleotide technologies. As a subsidiary of Ribo Life Science Co., Ltd., Ribocure benefits from a vertically i...
    Ribocure Pharmaceuticals AB is a newly established Swedish biotech company with a focus on developing cutting-edge RNA therapeutics. Specializing in rare diseases within the fields of cardiovascular, renal, and oncology, Ribocure is dedicated to discovering and developing groundbreaking drug assets using advanced oligonucleotide technologies. As a subsidiary of Ribo Life Science Co., Ltd., Ribocure benefits from a vertically integrated oligonucleotide research platform and excels in translational and clinical operations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ribocure PharmaceuticalsSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    SE-431 53 Mölndal
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ribocure.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ribocure-pharmaceuticals-ab/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ribo, Boehringer Progress siRNA Program for MASH
    Ribo, Boehringer Progress siRNA Program for MASH

    06 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ribo-and-boehringer-ingelheim-further-progress-their-sirna-program-for-metabolic-dysfunction-associated-steatohepatitis-mash-302764083.html

    PR NEWSWIRE
    06 May 2026
    Share Share
    Madrigal Pens $4.4B Deal For siRNA Drugs In Fresh Rezdiffra Play
    Madrigal Pens $4.4B Deal For siRNA Drugs In Fresh Rezdiffra Play

    12 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/madrigal-pens-44b-deal-ribos-sirna-programs-latest-rezdiffra-mash-play

    FIERCE BIOTECH
    12 Feb 2026
    Share Share
    Ribo Receives EMA Orphan Drug Designation For sIRNA RBD1016
    Ribo Receives EMA Orphan Drug Designation For sIRNA RBD1016

    25 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ribo-granted-ema-orphan-drug-designation-for-sirna-therapeutic-rbd1016-for-hepatitis-delta-virus-hdv-infection-302593812.html

    PR NEWSWIRE
    25 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search